Kevin P. Kerns

Array ( [id] => 5189058 [patent_doc_number] => 20070167367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'HETERODIMERIC FOUR HELIX BUNDLE CYTOKINES' [patent_app_type] => utility [patent_app_number] => 11/675890 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20219 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167367.pdf [firstpage_image] =>[orig_patent_app_number] => 11675890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746160 [patent_doc_number] => 20080090762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Epithelum-derived T-cell factor' [patent_app_type] => utility [patent_app_number] => 11/704726 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18283 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090762.pdf [firstpage_image] =>[orig_patent_app_number] => 11704726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151093 [patent_doc_number] => 07678373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Anti-FGF19 antibodies and methods using same' [patent_app_type] => utility [patent_app_number] => 11/673411 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 50 [patent_no_of_words] => 56401 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678373.pdf [firstpage_image] =>[orig_patent_app_number] => 11673411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253262 [patent_doc_number] => 20070134718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Use of interleukin-15' [patent_app_type] => utility [patent_app_number] => 11/703974 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8682 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134718.pdf [firstpage_image] =>[orig_patent_app_number] => 11703974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797858 [patent_doc_number] => 20080009444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Biologically active complex of NR6 and cardiotrophin-like-cytokine' [patent_app_type] => utility [patent_app_number] => 11/704086 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15058 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009444.pdf [firstpage_image] =>[orig_patent_app_number] => 11704086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791668 [patent_doc_number] => 20080292641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Antigenic GM-CSF peptides and antibodies to GM-CSF' [patent_app_type] => utility [patent_app_number] => 11/672902 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26811 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292641.pdf [firstpage_image] =>[orig_patent_app_number] => 11672902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292496 [patent_doc_number] => 07544789 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-06-09 [patent_title] => 'DNA encoding Toxoplasma gondii rDGP5p protein' [patent_app_type] => utility [patent_app_number] => 11/701872 [patent_app_country] => US [patent_app_date] => 2007-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12206 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544789.pdf [firstpage_image] =>[orig_patent_app_number] => 11701872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069507 [patent_doc_number] => 20070190609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Nucleic acid encoding an interleukin-9 receptor variant' [patent_app_type] => utility [patent_app_number] => 11/700260 [patent_app_country] => US [patent_app_date] => 2007-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14747 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190609.pdf [firstpage_image] =>[orig_patent_app_number] => 11700260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274083 [patent_doc_number] => 07560247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Nucleic acids encoding anti-IL-12 antibodies, and methods of production' [patent_app_type] => utility [patent_app_number] => 11/668256 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 31345 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560247.pdf [firstpage_image] =>[orig_patent_app_number] => 11668256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625152 [patent_doc_number] => 20100034811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'THERAPEUTIC AGENTS FOR DISEASES INVOLVING CHOROIDAL NEOVASCULARIZATION' [patent_app_type] => utility [patent_app_number] => 12/161733 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11794 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034811.pdf [firstpage_image] =>[orig_patent_app_number] => 12161733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368403 [patent_doc_number] => 20090305962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'IL-6 binding proteins' [patent_app_type] => utility [patent_app_number] => 11/655776 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 48568 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305962.pdf [firstpage_image] =>[orig_patent_app_number] => 11655776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977316 [patent_doc_number] => 20070218549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Compositions comprising conditioned cell culture media and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/619630 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13426 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218549.pdf [firstpage_image] =>[orig_patent_app_number] => 11619630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4547452 [patent_doc_number] => 07820155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Methods of treating cancer comprising administering an interleukin-6 antibody variable region' [patent_app_type] => utility [patent_app_number] => 11/647992 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10879 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820155.pdf [firstpage_image] =>[orig_patent_app_number] => 11647992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079130 [patent_doc_number] => 20070122354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Storage stable powder compositions of interleukin-4 receptor' [patent_app_type] => utility [patent_app_number] => 11/644150 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14832 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122354.pdf [firstpage_image] =>[orig_patent_app_number] => 11644150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040232 [patent_doc_number] => 20070092514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Novel secreted immunomodulatory proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/643252 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 34641 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092514.pdf [firstpage_image] =>[orig_patent_app_number] => 11643252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971264 [patent_doc_number] => 20070111266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'ANTIBODIES TO MURINE ZCYTOR17 LIGAND' [patent_app_type] => utility [patent_app_number] => 11/613091 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 80417 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111266.pdf [firstpage_image] =>[orig_patent_app_number] => 11613091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095532 [patent_doc_number] => 20070117141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Identification and cloning of a full-length human clnk-related gene, MIST (mast cell immunoreceptor signal transducer)' [patent_app_type] => utility [patent_app_number] => 11/640775 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 37669 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117141.pdf [firstpage_image] =>[orig_patent_app_number] => 11640775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135998 [patent_doc_number] => 20070077627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'MURINE ZCYTOR17 LIGAND POLYPEPTIDES AND POLYNUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 11/610126 [patent_app_country] => US [patent_app_date] => 2006-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 80432 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077627.pdf [firstpage_image] =>[orig_patent_app_number] => 11610126 [rel_patent_id] =>[rel_patent_doc_number] =>)